FindTrial
Sign In

Development and research of biodosimetry method by genome analysis using human peripheral blood.

Development and research of biodosimetry method by genome analysis using human peripheral blood. - Development and research of biodosimetry method by genome analysis.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048513
Enrollment
3
Registered
2022-09-01
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A healthy person capable of giving consent for participation in this study and who can read and understand the consent document.

Exclusion criteria

Exclusion criteria: Persons who have been or may be found to have coerced a socially vulnerable person.

Design outcomes

Primary

MeasureTime frame
Types and frequencies of mutations in the nucleotide sequence of genomic DNA in cells 2 hours or later after irradiation of ionizing radiation.—

Countries

Japan

Contacts

Public ContactKotaro Ishii

National Institutes for Quantum Science and Technology Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences

ishii.kotaro@qst.go.jp043-206-6294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026